A Decade of CRISPR Gene Editing in China and Beyond: A Scientometric Landscape.
CRISPR J
; 4(3): 313-320, 2021 06.
Article
em En
| MEDLINE
| ID: mdl-34152220
Since its Nobel Prize-winning breakthrough in 2012, CRISPR-Cas-based gene-editing system has emerged as one of the most promising biotechnologies in decades. In this article, we present an objective and comprehensive evaluation of CRISPR-based gene-editing technologies, including base editing and prime editing, based on the bibliometric analysis of 22,902 published records. We also assessed the status of CRISPR gene-editing technologies in academia from 2010 to 2020 globally, with respect to countries, institutions, and researchers, and used text clustering methods to assess technical trends and research hotspots. Our results indicate, not surprisingly, that this is a thriving and prominent area of research. By comparing the relevance and growth of CRISPR gene-editing technologies in China with other countries by several metrics, we show that the Chinese scientific community attaches considerable importance to the field of plant genome engineering, with more scholars from agricultural sectors than other sectors.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sistemas CRISPR-Cas
/
Edição de Genes
País/Região como assunto:
Asia
Idioma:
En
Revista:
CRISPR J
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
China
País de publicação:
Estados Unidos